tradingkey.logo
tradingkey.logo
Search

KORU Medical Systems Inc

KRMD
Add to Watchlist
3.830USD
-0.070-1.79%
Close 05/18, 16:00ETQuotes delayed by 15 min
175.92MMarket Cap
LossP/E TTM

KORU Medical Systems Inc

3.830
-0.070-1.79%

More Details of KORU Medical Systems Inc Company

KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

KORU Medical Systems Inc Info

Ticker SymbolKRMD
Company nameKORU Medical Systems Inc
IPO dateOct 27, 1993
CEOTharby (Linda M)
Number of employees80
Security typeOrdinary Share
Fiscal year-endOct 27
Address100 Corporate Drive
CityMAHWAH
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07430
Phone18454692042
Websitehttps://www.korumedical.com/
Ticker SymbolKRMD
IPO dateOct 27, 1993
CEOTharby (Linda M)

Company Executives of KORU Medical Systems Inc

Name
Name/Position
Position
Shareholding
Change
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.19M
-78.56%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
300.13K
+82.20%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
--
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
97.57K
+3.56%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
94.94K
+3.66%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
94.58K
+3.67%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
47.74K
+7.27%
Mr. Joseph M. Manko, Jr., J.D.
Mr. Joseph M. Manko, Jr., J.D.
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Thomas (Tom) Adams
Mr. Thomas (Tom) Adams
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.19M
-78.56%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
300.13K
+82.20%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
--
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
97.57K
+3.56%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
94.94K
+3.66%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
94.58K
+3.67%

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Domestic Core
27.99M
68.06%
International Core
10.88M
26.46%
Novel Therapies
2.25M
5.48%
By RegionUSD
Name
Revenue
Proportion
Domestic
30.24M
73.52%
International
10.89M
26.48%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Domestic Core
27.99M
68.06%
International Core
10.88M
26.46%
Novel Therapies
2.25M
5.48%

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Horton Capital Management LLC
11.03%
First Light Asset Management, LLC
9.17%
Topline Capital Management, LLC
8.58%
BlackRock Institutional Trust Company, N.A.
4.72%
Vanguard Capital Management, LLC
3.67%
Other
62.83%
Shareholders
Shareholders
Proportion
Horton Capital Management LLC
11.03%
First Light Asset Management, LLC
9.17%
Topline Capital Management, LLC
8.58%
BlackRock Institutional Trust Company, N.A.
4.72%
Vanguard Capital Management, LLC
3.67%
Other
62.83%
Shareholder Types
Shareholders
Proportion
Hedge Fund
21.32%
Investment Advisor
18.27%
Investment Advisor/Hedge Fund
16.57%
Individual Investor
7.89%
Pension Fund
0.90%
Research Firm
0.82%
Bank and Trust
0.14%
Insurance Company
0.03%
Other
34.05%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
188
28.85M
62.71%
-129.29K
2025Q4
180
26.41M
57.02%
-1.16M
2025Q3
175
25.43M
54.99%
-237.14K
2025Q2
181
28.37M
61.38%
+1.59M
2025Q1
185
26.98M
58.55%
-3.80M
2024Q4
166
28.05M
61.23%
-2.99M
2024Q3
157
26.45M
57.75%
-1.49M
2024Q2
155
27.99M
61.12%
-3.90M
2024Q1
138
29.57M
64.66%
-1.94M
2023Q4
141
31.83M
69.81%
-3.05M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Horton Capital Management LLC
5.06M
10.92%
-809.18K
-13.78%
Feb 13, 2026
First Light Asset Management, LLC
4.21M
9.08%
-317.23K
-7.01%
Dec 31, 2025
Topline Capital Management, LLC
3.94M
8.5%
+292.77K
+8.03%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
2.17M
4.68%
+235.36K
+12.17%
Dec 31, 2025
Tharby (Linda M)
2.13M
4.59%
+10.21K
+0.48%
Mar 16, 2026
Geode Capital Management, L.L.C.
1.02M
2.21%
+16.06K
+1.60%
Dec 31, 2025
Signia Capital Management, LLC
674.92K
1.46%
+674.92K
--
Dec 31, 2025
Manko (Joseph M JR)
782.55K
1.69%
+282.35K
+56.45%
Feb 13, 2026
Meros Investment Management, LP
782.39K
1.69%
-66.52K
-7.84%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.03%
iShares Russell 2000 ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0%
DFA Dimensional US Sustainability Core 1 ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI